Free Trial

Iovance Biotherapeutics (IOVA) News Today

Iovance Biotherapeutics logo
$3.70 +0.08 (+2.21%)
Closing price 05/11/2026 04:00 PM Eastern
Extended Trading
$3.76 +0.06 (+1.62%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IOVA Latest News

Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
Chardan Maintains a Buy on Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics Inc
Microscopic view of cancer cells on a pathology slide, representing oncology research and cancer drug development in biotech.
Why 2 Small Biotechs May Hold the Key to New Cancer Treatments
Iovance and ImmunityBio have doubled and quadrupled in share price so far this year, respectively, thanks to powerful cancer medicines that could upend care.
Get Iovance Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IOVA Media Mentions By Week

IOVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IOVA
News Sentiment

0.10

0.49

Average
Medical
News Sentiment

IOVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IOVA Articles
This Week

18

9

IOVA Articles
Average Week

Get the Latest News and Ratings for IOVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:IOVA) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners